Australian Natural Therapeutics Group (ANTG) works to combine research with cultivation and extraction systems to produce top quality Australian cannabinoid-based medicines for patients worldwide. They are the only Good Manufacturing Practices (GMP) and Good Agricultural and Collection Practices (GACP) certified producers of Australian grown, Australian made cannabis flower. They focus on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

ANTG’s medicinal cannabis products come with an approved prescription via the Therapeutic Goods Administration’s Special Access Scheme or via Authorised Prescriber applications. Their products are distributed through Anspec, a specialised wholesaler of healthcare products and equipment including pharmaceuticals. Their medicinal cannabis products also conform with the Therapeutic Goods Standards for Medicinal Cannabis (TG093 & TG0100) ensuring they are free from harmful contaminants such as moulds, microbials and yeast.

Their company takes pride in producing consistent high-quality medicinal cannabis with a variable ratio of CBD and THC, allowing for treatment tailored to individual patient needs. Plants are grown under the sun in an all-natural renewable medium without using chemical pesticides. They are licensed for cannabis research, medicinal cannabis cultivation and manufacturing, medicinal cannabis export, medicinal cannabis import, Schedule 8 wholesale supply (NSW) and hemp production (NSW).

ANTG’s processes are environmentally friendly and compliant with their carbon footprint policy. Their facilities are equipped with green water systems and specialised waste treatment procedures. For more information, they can be contacted through email at [email protected], or call them at 1800 287 628.